Combination of DLBS1425 With Anthracyclin-based Regimen as a Neoadjuvant Therapy in Subjects With Stage II or III Breast Cancer.
Phase of Trial: Phase II/III
Latest Information Update: 10 May 2013
At a glance
- Drugs Phaleria macrocarpa (Primary) ; Cyclophosphamide; Doxorubicin; Epirubicin; Fluorouracil
- Indications Breast cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 17 Oct 2012 Planned end date changed from 1 Nov 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 16 Sep 2011 New trial record